TW23242 Project Successfully Completes National Enrollment on May 12, 2025

The TW23242 project successfully completed national enrollment on May 12, 2025. This project is a multicenter, single-blind, positive-drug-controlled clinical study conducted by Totrial Medical Research (Wuxi) Co., Ltd. as the CRO, in collaboration with multiple centers across the country. It aims to explore the safety and efficacy of perioperative colloidal products in humans.

Totrial progressed as planned and achieved the enrollment goal in just 5 months through joint efforts with various research centers. We would like to express our heartfelt thanks to the clinical operations, medical, and data management teams, as well as all cooperative research centers, investigators, and sponsor teams. At the same time, we remind all parties to continue to uphold a rigorous attitude to ensure the quality of subsequent stages.